APPLICATION OF CART19 TO DEPLETE NORMAL B-CELLS FOR TOLERANCE INDUCTION

摘要

The invention relates to compositions and methods for the induction of tolerance in humans. The invention includes the introduction of a genetically modified T cell expressing CAR, where CAR contains an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.